Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-12-2023 | Vilanterol | Case report

Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide/vilanterol/fluticasone-furoate interaction

Adrenal insufficiency

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Metadata
Title
Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide/vilanterol/fluticasone-furoate interaction
Adrenal insufficiency
Publication date
01-12-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-52022-x

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Multiple drugs

Case report

Multiple drugs